Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth ...

Truist Financial analyst Jailendra Singh maintained a Hold rating on Medpace Holdings (MEDP – Research Report) today. The company’s shares ...

Introduction Cloud computing in the pharmaceutical industry refers to the use of cloud-based platforms and services to store, process, and anal ...

In the latest trading session, Veeva Systems (VEEV) closed at $237.81, marking a +0.26% move from the previous day.

Spire Wealth Management lowered its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 50.1% in the fourth ...

Highlights,Veeva Systems Inc. specializes in cloud-based solutions tailored for the life sciences sector.,The company has ...

To avoid a tug-of-war between scientific rigour and operational efficiency, we must focus on the user and data journeys of ...

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.11 = US$643m ÷ (US$6.5b - US$857m) (Based on the trailing twelve months to October 2024).

Wells Fargo analyst Stan Berenshteyn maintained a Hold rating on Doximity (DOCS – Research Report) yesterday and set a price target of $55.00.

Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...

CENTRAL TRUST Co decreased its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 11.0% during the 4th ...

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Garty, chief technology officer, clinical data, provided his key takeaways from a panel he participated in on the growing interest ...